SAR of benzoylpyridines and benzophenones as p38alpha MAP kinase inhibitors with oral activity.
Revesz, Laszlo, Blum, Ernst, Di Padova, Franco E., Buhl, Thomas, Feifel, Roland, Gram, Hermann, Hiestand, Peter, Manning, Ute and Rucklin, Gerard (2004) SAR of benzoylpyridines and benzophenones as p38alpha MAP kinase inhibitors with oral activity. Bioorganic & Medicinal Chemistry Letters, 14 (13). pp. 3601-3605. ISSN 0960-894X
Abstract
Benzoylpyridines and benzophenones were synthesized and evaluated in vitro as p38alpha inhibitors and in vivo in several models of rheumatoid arthritis. Oral activity was found to depend upon substitution: 1,1-dimethylpropynylamine substituted benzophenone 10b (IC50: 14 nM) and pyridinoyl substituted benzimidazole 17b (IC50: 21 nM) showed highest efficacy and selectivity with ED50s of 9.5 and 8.6 mg/kg p.o. in CIA.
Item Type: | Article |
---|---|
Related URLs: | |
Additional Information: | author can archive post-print (ie final draft post-refereeing); Publisher's version/PDF cannot be used |
Related URLs: | |
Date Deposited: | 14 Dec 2009 13:55 |
Last Modified: | 31 Jan 2013 01:07 |
URI: | https://oak.novartis.com/id/eprint/750 |